You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Ranbaxy Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for RANBAXY, and what generic and branded alternatives to RANBAXY drugs are available?

RANBAXY has forty-five approved drugs.

There are fifteen tentative approvals on RANBAXY drugs.

Summary for Ranbaxy
US Patents:0
Tradenames:33
Ingredients:29
NDAs:45
PTAB Cases with Ranbaxy as petitioner: See PTAB cases with Ranbaxy as petitioner

Drugs and US Patents for Ranbaxy

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy AVENTYL nortriptyline hydrochloride SOLUTION;ORAL 014685-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Ranbaxy Labs Ltd OFLOXACIN ofloxacin TABLET;ORAL 076220-003 Sep 2, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up
Ranbaxy Labs Ltd LORATADINE loratadine SYRUP;ORAL 076529-001 Aug 20, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.